以嶺藥業(002603.SZ):解鬱除煩膠囊獲得藥品註冊證書
格隆匯12月21日丨以嶺藥業(002603.SZ)公佈,近日,公司收到國家藥品監督管理局核准簽發的《藥品註冊證書》。藥品通用名稱:解鬱除煩膠囊。
解鬱除煩膠囊是公司在臨牀經驗方基礎上自主研製的中藥創新藥,其功能主治為:解鬱化痰,清熱除煩。適用於輕、中度抑鬱症中醫辨證屬氣鬱痰阻、鬱火內擾證,症見情緒低落、心緒不寧、咽中如有異物、胸脘痞悶、食慾不振、易歎氣、失眠多夢、頭暈耳鳴、口苦咽乾、大便祕結,舌紅苔膩、脈弦滑等。公司擁有該藥獨立完整的知識產權。
公司對該藥開展了多中心、隨機、雙盲雙模擬、安慰劑和鹽酸氟西汀片平行對照的臨牀試驗,結果顯示:主要療效指標漢密爾頓抑鬱量表(HAMD-17)評分較基線下降值,試驗組療效優於安慰劑組,非劣於鹽酸氟西汀片組;改善精神抑鬱、心緒不寧、胸脘痞悶、食慾不振、善太息(易歎氣)、失眠多夢、頭暈耳鳴、咽堵(咽中如有異物)、口苦咽乾、大便祕結等中醫證候單項症狀評分以及漢密爾頓焦慮量表(HAMA)評分。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.